Global Flu Vaccines Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS11254 | Category: Healthcare | Pages: 108 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Flu Vaccines, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccines.

The Flu Vaccines market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Flu Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccines manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Flu Vaccines market size in 2022 is 8164.8 million US dollars, and it is expected to be 14830.0 million US dollars by 2029, with a compound annual growth rate of 8.90% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Flu Vaccines market include AstraZeneca (U.K.), BioDiem (Canada), Novasep (France), MerckKGaA (Germany), and Charles River Laboratories (U.K.). The share of the top 3 players in the Flu Vaccines market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Flu Vaccines market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Seasonal accounted for XX% of Flu Vaccines market in 2022. Zoonotic share of XX%.
Pediatric accounted for XX% of the Flu Vaccines market in 2022. Adult accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Flu Vaccines market status and forecast by region.
Chapters 2-3: Segmented the global Flu Vaccines market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Flu Vaccines market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Flu Vaccines market country segmentation data.
Chapter 10: Analyzes the main companies in the Flu Vaccines industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
AstraZeneca (U.K.)
BioDiem (Canada)
Novasep (France)
MerckKGaA (Germany)
Charles River Laboratories (U.K.)
uniQure N.V. (Netherlands)
Waisman Biomanufacturing (U.S.)
Creative-Biogene (U.S.)
Aldevron (U.S.)
Oxford Biomedica (U.K.)
Thermo Fisher Scientific Inc (U.S.)
Fujifilm Corporation (Japan)
Spark Therapeutics Inc. (U.S.)
ABL Inc. (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Brammer Bio (U.S.)
Pfizer Inc. (U.S.)

Types list
Seasonal
Zoonotic

Application list
Pediatric
Adult

Table of Content

1 Flu Vaccines Market Overview
1.1 Flu Vaccines Product Overview
1.1.1 Flu Vaccines Product Scope
1.1.2 Flu Vaccines Market Status and Outlook
1.2 Global Flu Vaccines Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Flu Vaccines Market Size by Region (2018-2029)
1.4 Global Flu Vaccines Historic Market Size by Region (2018-2023)
1.5 Global Flu Vaccines Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Flu Vaccines Market Size (2018-2029)
1.6.1 North America Flu Vaccines Market Size (2018-2029)
1.6.2 Europe Flu Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific Flu Vaccines Market Size (2018-2029)
1.6.4 Latin America Flu Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa Flu Vaccines Market Size (2018-2029)
2 Flu Vaccines Market Overview by Type
2.3 Global Flu Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Flu Vaccines Historic Market Size by Type (2018-2023)
2.5 Global Flu Vaccines Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Flu Vaccines Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Flu Vaccines Market Size Breakdown by Type
2.6.3 Asia-Pacific Flu Vaccines Market Size Breakdown by Type
2.6.4 Latin America Flu Vaccines Market Size Breakdown by Type
2.6.5 Middle East and Africa Flu Vaccines Market Size Breakdown by Type
3 Flu Vaccines Market Overview by Application
3.3 Global Flu Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Flu Vaccines Historic Market Size by Application (2018-2023)
3.5 Global Flu Vaccines Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Flu Vaccines Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Flu Vaccines Market Size Breakdown by Application
3.6.3 Asia-Pacific Flu Vaccines Market Size Breakdown by Application
3.6.4 Latin America Flu Vaccines Market Size Breakdown by Application
3.6.5 Middle East and Africa Flu Vaccines Market Size Breakdown by Application
4 Flu Vaccines Competition Analysis by Players
4.1 Global Flu Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Vaccines as of 2022)
4.3 Date of Key Players Enter into Flu Vaccines Market
4.4 Global Top Players Flu Vaccines Headquarters and Area Served
4.5 Key Players Flu Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 Flu Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Flu Vaccines Market Segment by Country
5.1 North America Flu Vaccines Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Flu Vaccines Market Segment by Country
6.1 Europe Flu Vaccines Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Flu Vaccines Market Segment by Country
7.1 Asia-Pacific Flu Vaccines Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Flu Vaccines Market Segment by Country
8.1 Latin America Flu Vaccines Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Flu Vaccines Market Segment by Country
9.1 Middle East & Africa Flu Vaccines Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  AstraZeneca (U.K.)
10.1.1 AstraZeneca (U.K.) Information
10.1.2 Business Overview
10.1.3 AstraZeneca (U.K.) Flu Vaccines Revenue, Gross Margin
10.1.4 Flu Vaccines Products Offered
10.1.5 AstraZeneca (U.K.) Recent Development
10.2  BioDiem (Canada)
10.2.1 BioDiem (Canada) Information
10.2.2 Business Overview
10.2.3 BioDiem (Canada) Flu Vaccines Revenue, Gross Margin
10.2.4 Flu Vaccines Products Offered
10.2.5 BioDiem (Canada) Recent Development
10.3  Novasep (France)
10.3.1 Novasep (France) Information
10.3.2 Business Overview
10.3.3 Novasep (France) Flu Vaccines Revenue, Gross Margin
10.3.4 Flu Vaccines Products Offered
10.3.5 Novasep (France) Recent Development
10.4  MerckKGaA (Germany)
10.4.1 MerckKGaA (Germany) Information
10.4.2 Business Overview
10.4.3 MerckKGaA (Germany) Flu Vaccines Revenue, Gross Margin
10.4.4 Flu Vaccines Products Offered
10.4.5 MerckKGaA (Germany) Recent Development
10.5  Charles River Laboratories (U.K.)
10.5.1 Charles River Laboratories (U.K.) Information
10.5.2 Business Overview
10.5.3 Charles River Laboratories (U.K.) Flu Vaccines Revenue, Gross Margin
10.5.4 Flu Vaccines Products Offered
10.5.5 Charles River Laboratories (U.K.) Recent Development
10.6  uniQure N.V. (Netherlands)
10.6.1 uniQure N.V. (Netherlands) Information
10.6.2 Business Overview
10.6.3 uniQure N.V. (Netherlands) Flu Vaccines Revenue, Gross Margin
10.6.4 Flu Vaccines Products Offered
10.6.5 uniQure N.V. (Netherlands) Recent Development
10.7  Waisman Biomanufacturing (U.S.)
10.7.1 Waisman Biomanufacturing (U.S.) Information
10.7.2 Business Overview
10.7.3 Waisman Biomanufacturing (U.S.) Flu Vaccines Revenue, Gross Margin
10.7.4 Flu Vaccines Products Offered
10.7.5 Waisman Biomanufacturing (U.S.) Recent Development
10.8  Creative-Biogene (U.S.)
10.8.1 Creative-Biogene (U.S.) Information
10.8.2 Business Overview
10.8.3 Creative-Biogene (U.S.) Flu Vaccines Revenue, Gross Margin
10.8.4 Flu Vaccines Products Offered
10.8.5 Creative-Biogene (U.S.) Recent Development
10.9  Aldevron (U.S.)
10.9.1 Aldevron (U.S.) Information
10.9.2 Business Overview
10.9.3 Aldevron (U.S.) Flu Vaccines Revenue, Gross Margin
10.9.4 Flu Vaccines Products Offered
10.9.5 Aldevron (U.S.) Recent Development
10.10  Oxford Biomedica (U.K.)
10.10.1 Oxford Biomedica (U.K.) Information
10.10.2 Business Overview
10.10.3 Oxford Biomedica (U.K.) Flu Vaccines Revenue, Gross Margin
10.10.4 Flu Vaccines Products Offered
10.10.5 Oxford Biomedica (U.K.) Recent Development
10.11  Thermo Fisher Scientific Inc (U.S.)
10.11.1 Thermo Fisher Scientific Inc (U.S.) Information
10.11.2 Business Overview
10.11.3 Thermo Fisher Scientific Inc (U.S.) Flu Vaccines Revenue, Gross Margin
10.11.4 Flu Vaccines Products Offered
10.11.5 Thermo Fisher Scientific Inc (U.S.) Recent Development
10.12  Fujifilm Corporation (Japan)
10.12.1 Fujifilm Corporation (Japan) Information
10.12.2 Business Overview
10.12.3 Fujifilm Corporation (Japan) Flu Vaccines Revenue, Gross Margin
10.12.4 Flu Vaccines Products Offered
10.12.5 Fujifilm Corporation (Japan) Recent Development
10.13  Spark Therapeutics Inc. (U.S.)
10.13.1 Spark Therapeutics Inc. (U.S.) Information
10.13.2 Business Overview
10.13.3 Spark Therapeutics Inc. (U.S.) Flu Vaccines Revenue, Gross Margin
10.13.4 Flu Vaccines Products Offered
10.13.5 Spark Therapeutics Inc. (U.S.) Recent Development
10.14  ABL Inc. (U.S.)
10.14.1 ABL Inc. (U.S.) Information
10.14.2 Business Overview
10.14.3 ABL Inc. (U.S.) Flu Vaccines Revenue, Gross Margin
10.14.4 Flu Vaccines Products Offered
10.14.5 ABL Inc. (U.S.) Recent Development
10.15  Boehringer Ingelheim International GmbH. (Germany)
10.15.1 Boehringer Ingelheim International GmbH. (Germany) Information
10.15.2 Business Overview
10.15.3 Boehringer Ingelheim International GmbH. (Germany) Flu Vaccines Revenue, Gross Margin
10.15.4 Flu Vaccines Products Offered
10.15.5 Boehringer Ingelheim International GmbH. (Germany) Recent Development
10.16  Brammer Bio (U.S.)
10.16.1 Brammer Bio (U.S.) Information
10.16.2 Business Overview
10.16.3 Brammer Bio (U.S.) Flu Vaccines Revenue, Gross Margin
10.16.4 Flu Vaccines Products Offered
10.16.5 Brammer Bio (U.S.) Recent Development
10.17  Pfizer Inc. (U.S.)
10.17.1 Pfizer Inc. (U.S.) Information
10.17.2 Business Overview
10.17.3 Pfizer Inc. (U.S.) Flu Vaccines Revenue, Gross Margin
10.17.4 Flu Vaccines Products Offered
10.17.5 Pfizer Inc. (U.S.) Recent Development
11 Flu Vaccines Market Dynamics
11.1 Flu Vaccines Industry Trends
11.2 Flu Vaccines Growth Drivers
11.3 Flu Vaccines Market Challenges
11.4 Flu Vaccines Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Flu Vaccines Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?